首页> 外文期刊>Liver international : >Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease
【24h】

Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease

机译:慢性肝病中25-羟基维生素D水平与肝功能障碍和死亡率的关系

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Previous studies suggest that chronic liver disease may be related to vitamin D deficiency. It is, however, not known whether 25(OH)D levels are associated with incident hepatic decompensation and mortality in chronic liver failure. Aims: We aimed to evaluate whether 25(OH)D serum levels are associated with Child-Pugh (CP) score, model for end-stage liver disease (MELD) score, occurrence of hepatic decompensation, and survival in patients with cirrhosis. Methods: We enrolled 75 consecutive cirrhotic patients admitted to our outpatient liver clinic (32% females; age: 58 ± 11 years; aetiology alcohol in 61%). At baseline, 25(OH)D was determined and the degree of liver dysfunction was estimated by CP and MELD score. Thereafter patients were followed-up with respect to hepatic decompensation and mortality. Results: 25(OH)D levels averaged 16.0 ± 9.2 ng/ml and were inversely correlated with MELD score (r = -0.34, P = 0.003) and CP score (r = -0.21, P = 0.080). Thirty-seven patients developed hepatic decompensation and 24 patients died during a median follow-up of 3.6 years. Age- and gender-adjusted relative risk (with 95% confidence interval) was 6.37 (1.75-23.2; P = 0.005) for hepatic decompensation and 4.31 (1.38-13.5; P = 0.012) for mortality within the first vs the third 25(OH)D tertile but these associations were largely attenuated towards non-significant trends after additional adjustments for CP or MELD score. Conclusions: Our findings show a significant association of 25(OH)D with the degree of liver dysfunction and suggest that low 25(OH)D levels may predict hepatic decompensation and mortality in patients with chronic liver failure.
机译:背景:以前的研究表明,慢性肝病可能与维生素D缺乏症有关。然而,尚不知道25(OH)D水平是否与慢性肝功能衰竭的入射肝失代偿和死亡率相关。目的:我们旨在评估25(OH)D血清水平是否与Child-Pugh(CP)评分,终末期肝病(MELD)评分模型,肝代偿失调的发生以及肝硬化患者的生存率相关。方法:我们招募了75位连续进入肝门诊的肝硬化患者(女性32%;年龄:58±11岁;病因酒精中61%)。在基线时,确定25(OH)D,并通过CP和MELD评分评估肝功能不全的程度。此后,对患者进行肝失代偿和死亡率的随访。结果:25(OH)D水平平均为16.0±9.2 ng / ml,并与MELD得分(r = -0.34,P = 0.003)和CP得分(r = -0.21,P = 0.080)呈负相关。在中位随访期3.6年中,有37例患者出现了肝代偿失调,有24例患者死亡。年龄和性别校正后的肝脏代偿失调的相对风险(置信区间为95%)为6.37(1.75-23.2; P = 0.005),死亡率在第一个25岁与第三个25岁之间为4.31(1.38-13.5; P = 0.012)。 OH)D三分法,但在对CP或MELD分数​​进行额外调整后,这些关联在很大程度上趋向于无明显趋势。结论:我们的发现表明25(OH)D与肝功能障碍程度密切相关,并提示低25(OH)D水平可预测慢性肝衰竭患者的肝功能不全和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号